Holen Sie sich die Stockscreener-App
28.82
3.48%
0.97
Handel nachbörslich:
28.82
Caredx Inc Aktie (CDNA) Neueste Nachrichten
1K9 Forecast — Price Target — Prediction for 2027 - TradingView
Price to sales forward of CareDx, Inc. – BOATS:CDNA - TradingView
Price to earnings forward of CareDx, Inc. – BOATS:CDNA - TradingView
CDNA Forecast — Price Target — Prediction for 2027 - TradingView
CareDx, Inc. Actuals & Estimates (NASDAQ:CDNA) - TradingView
CareDx Inc (CDNA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Caredx Inc stock hits 52-week high at 26.7 USD - Investing.com
Caredx Inc stock hits 52-week high at 26.7 USD By Investing.com - Investing.com Canada
CareDx Inc (CDNA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CareDx's CEO Sells 17K Shares - Yahoo Finance
CareDx (CDNA) Stock Could Be 1.5% Overvalued After AlloSure Study Buzz - Sahm
Responsive Playbooks and the CDNA Inflection - Stock Traders Daily
CareDx (NASDAQ:CDNA) Passes Both the Minervini Trend Template and High Growth Momentum Tests - ChartMill
CareDx (CDNA) Moves 11.5% Higher: Will This Strength Last? - Yahoo Finance
CareDx Inc (CDNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
CareDx Inc (CDNA) Institutional Confidence - TradingKey
CareDx Inc (CDNA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
CareDx (CDNA) Showcases Innovations at American Transplant Congr - GuruFocus
CareDx Inc (CDNA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
CareDx presents transplant monitoring data at medical congress - Investing.com
CareDx presents transplant monitoring data at medical congress By Investing.com - Investing.com Nigeria
CareDx Precision Medicine Diagnostics Showcased in Over 30 Abstracts and 9 Oral Presentations at the 2026 American Transplant Congress - Business Wire
How New AlloSure Kidney Prognostic Evidence At CareDx (CDNA) Has Changed Its Investment Story - Sahm
Insider Sell: CareDx Inc (CDNA) President and CEO Hanna John Wal - GuruFocus
CareDx Inc (CDNA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CareDx Inc (CDNA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CareDx Inc (CDNA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CareDx (CDNA) CEO sells 17,683 shares under 10b5-1 plan - Stock Titan
CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology - BioSpace
Insider Sell: Hannah Valantine Sells 12,103 Shares of CareDx Inc (CDNA) - GuruFocus
CareDx director Hannah Valantine sells $279,728 in stock By Investing.com - Investing.com India
CareDx director Hannah Valantine sells $279,728 in stock - Investing.com UK
New Analysis from CareDx (CDNA) Highlights Allograft Outcomes - GuruFocus
CareDx Inc (CDNA) Shares Fall 3.4% -- GF Value Says Still Overva - GuruFocus
Caredx Insider Sold Shares Worth $279,728, According to a Recent SEC Filing - marketscreener.com
CareDx (CDNA) director logs RSU grant and pre-planned share sale - Stock Titan
CareDx (CDNA) director receives 9,795-share RSU grant, holdings reach 58,943 - Stock Titan
CareDx (NASDAQ: CDNA) grants 9,795 RSUs to board member Riggsbee - Stock Titan
CareDx (CDNA) director Fred E. Cohen receives 9,795-share RSU grant - Stock Titan
CareDx (CDNA) director receives 9,795 RSUs in equity grant - Stock Titan
Director George Bickerstaff receives 9,795 RSUs at CareDx (NASDAQ: CDNA) - Stock Titan
CareDx (CDNA) director awarded 9,795 restricted stock units - Stock Titan
CareDx Shareholders Back Directors, Auditor and Equity Plan - The Globe and Mail
CareDx study links kidney test elevations to graft loss risk By Investing.com - Investing.com Nigeria
CareDx study links kidney test elevations to graft loss risk - Investing.com UK
CareDx sharpens precision diagnostics push with Naveris deal, AlloHeme plans - MSN
CareDx, Inc. Approves Amendment to 2024 Equity Incentive Plan and Reports 2026 Annual Meeting Results - Minichart
CareDx president and CEO John Hanna sells $528,442 in company stock - Investing.com India
CareDx president and CEO John Hanna sells $528,442 in company stock By Investing.com - Investing.com South Africa
CareDx shareholders approve equity plan amendment and elect directors at annual meeting - Investing.com Nigeria
Caredx Insider Sold Shares Worth $528,443, According to a Recent SEC Filing - Moomoo
CareDx (CDNA) CEO logs 21,998-share open-market stock sale - Stock Titan
[144] CareDx, Inc. SEC Filing - Stock Titan
CareDx (NASDAQ: CDNA) shareholders approve equity plan increase and board slate - Stock Titan
CareDx rebounds as draft LCD suggests no change in coverage - MSN
Caredx Inc stock hits 52-week high at $24.04 By Investing.com - Investing.com Nigeria
1.76%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):